UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Foot Pressure Wearable Sensors for Freezing of Gait Detection in Parkinson's Disease

Sensors (Basel, Switzerland), 2020-12, Vol.21 (1), p.128

2020

Volltextzugriff (PDF)

Drug Choices and Advancements for Managing Depression in Parkinson's Disease

Current neuropharmacology, 2020-01, Vol.18 (4), p.277-287

2020

Volltextzugriff (PDF)

Management and Treatment of Patients With Major Depressive Disorder and Chronic Diseases: A Multidisciplinary Approach

Frontiers in psychology, 2020-09, Vol.11, p.542444-542444

2020

Volltextzugriff (PDF)

Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease

Parkinsonism & related disorders, 2017-12, Vol.45, p.50-56

2017

Volltextzugriff (PDF)

Neuropsychiatric and cognitive symptoms and body side of onset of parkinsonism in unmedicated Parkinson's disease patients

Parkinsonism & related disorders, 2015-09, Vol.21 (9), p.1096-1100

2015

Volltextzugriff (PDF)

Immune System and Neuroinflammation in Idiopathic Parkinson's Disease: Association Analysis of Genetic Variants and miRNAs Interactions

Frontiers in genetics, 2021-06, Vol.12, p.651971-651971

2021

Volltextzugriff (PDF)

Narrative discourse production in Parkinson’s disease: Decoupling the role of cognitive-linguistic and motor speech changes

Heliyon, 2023-08, Vol.9 (8), p.e18633-e18633, Article e18633

2023

Volltextzugriff (PDF)

Feasibility and Utility of mHealth for the Remote Monitoring of Parkinson Disease: Ancillary Study of the PD_manager Randomized Controlled Trial

JMIR mHealth and uHealth, 2020-06, Vol.8 (6), p.e16414-e16414

2020

Volltextzugriff (PDF)

The Dopaminergic System in Peripheral Blood Lymphocytes: From Physiology to Pharmacology and Potential Applications to Neuropsychiatric Disorders

Current neuropharmacology, 2011-06, Vol.9 (2), p.278-288

2011

Volltextzugriff (PDF)

Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism

Brain and behavior, 2019-12, Vol.9 (12), p.e01448-n/a

2019

Volltextzugriff (PDF)

Cerebellar GABA Levels and Cognitive Interference in Parkinson's disease and Healthy Comparators

Journal of personalized medicine, 2020-12, Vol.11 (1), p.16

2020

Volltextzugriff (PDF)

Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease

Journal of personalized medicine, 2021-01, Vol.11 (1), p.51

2021

Volltextzugriff (PDF)

Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders

Journal of personalized medicine, 2021-08, Vol.11 (9), p.851

2021

Volltextzugriff (PDF)

Cortical thinning across Parkinson's disease stages and clinical correlates

Journal of the neurological sciences, 2019-03, Vol.398, p.31-38

2019

Volltextzugriff (PDF)

The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson's disease: an observational study

European journal of medical research, 2013-12, Vol.18 (1), p.60-60, Article 60

2013

Volltextzugriff (PDF)

Unraveling predictors affecting compliance to MRI in Parkinson's disease

Parkinsonism & related disorders, 2015-08, Vol.21 (8), p.964-967

2015

Volltextzugriff (PDF)

Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates

Parkinsonism & related disorders, 2018-09, Vol.54, p.62-67

2018

Volltextzugriff (PDF)

Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism

Pharmacological research, 2022-08, Vol.182, p.106338, Article 106338

2022

Volltextzugriff (PDF)

Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI

Sleep medicine, 2022-12, Vol.100, p.230-237

2022

Volltextzugriff (PDF)

Alpha-synuclein in salivary gland as biomarker for Parkinson's disease

Reviews in the neurosciences, 2019-07, Vol.30 (5), p.455-462

2019

Volltextzugriff (PDF)

Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

Lancet neurology, 2024-05, Vol.23 (5), p.465-476

2024

Volltextzugriff (PDF)

Morphometric changes in the reward system of Parkinson’s disease patients with impulse control disorders

Journal of neurology, 2015-12, Vol.262 (12), p.2653-2661

2015

Volltextzugriff (PDF)

Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson's disease

European neuropsychopharmacology, 2015-01, Vol.25 (1), p.69-76

2015

Volltextzugriff (PDF)

Neuropharmacology and behavior in planarians: Translations to mammals

Comparative biochemistry and physiology. Toxicology & pharmacology, 2008-05, Vol.147 (4), p.399-408

2008

Volltextzugriff (PDF)

Phosphorylated α-synuclein immunoreactivity in nerve fibers from minor salivary glands in Parkinson's disease

Parkinsonism & related disorders, 2017-05, Vol.38, p.99-101

2017

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(49)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Foot Pressure Wearable Sensors for Freezing of Gait Detection in Parkinson's Disease

Drug Choices and Advancements for Managing Depression in Parkinson's Disease

Management and Treatment of Patients With Major Depressive Disorder and Chronic Diseases: A Multidisciplinary Approach

Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease

Neuropsychiatric and cognitive symptoms and body side of onset of parkinsonism in unmedicated Parkinson's disease patients

Immune System and Neuroinflammation in Idiopathic Parkinson's Disease: Association Analysis of Genetic Variants and miRNAs Interactions

Narrative discourse production in Parkinson’s disease: Decoupling the role of cognitive-linguistic and motor speech changes

Feasibility and Utility of mHealth for the Remote Monitoring of Parkinson Disease: Ancillary Study of the PD_manager Randomized Controlled Trial

The Dopaminergic System in Peripheral Blood Lymphocytes: From Physiology to Pharmacology and Potential Applications to Neuropsychiatric Disorders

Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism

Cerebellar GABA Levels and Cognitive Interference in Parkinson's disease and Healthy Comparators

Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease

Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders

Cortical thinning across Parkinson's disease stages and clinical correlates

The impact of extended release dopamine agonists on prescribing patterns for therapy of early Parkinson's disease: an observational study

Unraveling predictors affecting compliance to MRI in Parkinson's disease

Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates

Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism

Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI

Alpha-synuclein in salivary gland as biomarker for Parkinson's disease

Safety and efficacy of continuous subcutaneous levodopa–carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial

Morphometric changes in the reward system of Parkinson’s disease patients with impulse control disorders

Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson's disease

Neuropharmacology and behavior in planarians: Translations to mammals

Phosphorylated α-synuclein immunoreactivity in nerve fibers from minor salivary glands in Parkinson's disease

Suchergebnisse filtern